⭐️⭐️⭐️⭐️⭐️ "A total no brainer"

⭐️⭐️⭐️⭐️⭐️ "Love this, so easy."

Spots is the easy way to track your skin, mole and cancer changes.

Spots Global Cancer Trial Database for secondary amenorrhea

Every month we try and update this database with for secondary amenorrhea cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.

The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.

Study titleNCT IDConditionsInterventionsEligibilityOrganizationLink
A Phase 3, Randomized, Three-Cycle, Double-Blind, Placebo-Controlled Study to Evaluate Induction of Secretory Conversion of Endometrium and Withdrawal Bleeding for Secondary AmenorrheaNCT02019589
Secondary Ameno...
Progesterone
Placebo
18 Years - 40 YearsTherapeuticsMD
Insulin Differences Between African-American and Caucasian Female Adolescents With Polycystic Ovary Syndrome (PCOS)NCT02052479
Polycystic Ovar...
PCOS
Frequently Samp...
12 Years - 18 YearsNationwide Children's Hospital
Insulin Differences Between African-American and Caucasian Female Adolescents With Polycystic Ovary Syndrome (PCOS)NCT02052479
Polycystic Ovar...
PCOS
Frequently Samp...
12 Years - 18 YearsNationwide Children's Hospital
Safety and Efficacy of PROMETRIUM® Capsules in Induction of Secretory ConversionNCT00160199
Secondary Ameno...
PROMETRIUM® 300...
PROMETRIUM® 400...
18 Years - 45 YearsSolvay Pharmaceuticals
A Phase 3, Randomized, Three-Cycle, Double-Blind, Placebo-Controlled Study to Evaluate Induction of Secretory Conversion of Endometrium and Withdrawal Bleeding for Secondary AmenorrheaNCT02019589
Secondary Ameno...
Progesterone
Placebo
18 Years - 40 YearsTherapeuticsMD
Logo

Take Control of Your Skin and Body Changes Today.

Try out Spots for free, set up only takes 2 mins.

spots app storespots app store

Join others from around the world: